Februar 23, 2021 + Jessica Di Palo
3 Minuten zu lesen
What you need to know when pitching to a healthtech investor!
Pitching a healthtech investor is not an easy exercise for many entrepreneurs because you may never get a second chance to make a good first impression!
When you are starting a presentation about your company, focus on setting the scene by describing the current environment with its related challenges and pain points. Then present the unmet medical need, which must be clearly identified in order to demonstrate how you are solving the issue and why your product is better than its competitors.
Entrepreneurs must be able to present the value their company is adding to stakeholders because healthcare is a value-based market where only ‘must-have’ solutions can survive and because insurance will never pay for ‘nice-to-have products’. The general constraint on healthcare spending continues to accentuate this fact.
The goal is to show that your solution has a competitive advantage and you are able to secure it with key assets such as (clinical) validation data, patents, a proprietary data set to train your machine learning or an existing customer network. These kinds of assets add a lot of value to your company because they de-risk the investment in the investor’s eyes.
A good value proposition with a sizeable cash amount is not equal to success without cornerstones demonstrating a feasible plan and the right capabilities to execute the vision. Your roadmap should include value inflection points, usually defined by target milestones, their related activities, and how the money raised is allocated over time.
This planning exercise is important and often underestimated by companies, but it provides clarity for an investor about the management’s view. The team must demonstrate technical knowledge and expertise, but also sales and marketing skills.
Exit scenarios need to be addressed with potential future buyers and timelines because most venture capital funds are closed-ended (normally 8-10 years lifespan), which means they need to be liquidated in a certain timeframe. Keep in mind that exit triggers the venture capitalist’s strategy!
The first interaction between an entrepreneur and an healthtech investor will start at two different sides of the table but might end up side by side, in the same boat. At the end of the journey, transparency, honesty, and open communication are essential for rowing faster together.
We wish you a lot of success when pitching to your next healthtech investor!
written by Dr. Christoph Kausch – Managing partner at MTIP.
Christoph Kausch selected by Real Deals as most influential for 2022
Christoph Kausch named by Real Deals most influential for 2022
MTIP leads €17 million financing round in virtual fertility clinic Apricity
New MTIP investment
MTIP leads the €20 million growth financing round in LynxCare
Largest capital round ever in digital health in Belgium
Pioneering the use of machine learning algorithms to turbo-charge drug development
Intelligencia revolutionizes drug development
The psychology of decision making
What makes a good investor?
MTIP schliesst zweiten Healthtech Growth Fonds mit $250 Millionen
MTIP schliesst zweiten Healthtech Fund
Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics
Cynerio's new product Cynerio Now!
MTIP invests in Mediktor
Dieser Text erscheint auf allen Übersichtsseiten (z.B. Story-Karussell)
MTIP invests in Mediktor
MTIP investiert in medizinischen Assistenten
SFDR Art. 8 or Art. 9? What’s the difference?
SFDR: getting the terminology right
MTIP participates in Oviva’s new $80m Series C funding
MTIP invests in Oviva
MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence
MTIP's new investment in Intelligencia
Leading brands revolutionize care journeys with Lumeon
How Lumeon orchestrates care journey
Trialbee – our hero in patient matching and recruiting for clinical trials
Trialbee - patient matching and recruiting
Digital healthcare: patient-first?
Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital
SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?
New SFDR obligations
MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation
First Closing of Fund II
How to pitch to a healthtech Investor
MTIP invests in Koa Health to make mental health treatment more accessible
New investment in Koa Health
MTIP scored fantastic grades in the UNPRI assessment report of 2020
UNPRI Report grades 2020
4 Health VCs Share Their Business Priorities and What is Next
MTIP invests in Trialbee
New investment in Trialbee
TytoCare closes $50 million round as the demand for telehealth accelerates
TytoCare closes new round